Nuvalent, Inc. (BOATS:NUVL) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James Flynn Other companies: Lite Strategy, Inc. (Non-Executive Director · Since at least Oct 31, 2023); Larimar Therapeutics, Inc. (Director · Since at least May 28, 2020); Synlogic Inc (Director · Mar 19, 2024 – Apr 26, 2025 · Past); BiomX Inc. (Director · Mar 15, 2024 – Apr 21, 2025 · Past); RiceBran Technologies (Director · Jan 3, 2024 – Jan 3, 2024 · Past); Oruka Therapeutics, Inc. (Director · Dec 15, 2022 – Jan 30, 2024 · Past); CareMax Inc (Director · Nov 17, 2022 – Nov 17, 2023 · Past); ARS Pharmaceuticals, Inc. (Director · Nov 8, 2022 – Nov 8, 2022 · Past); Da32 Life Science Tech Acquisition Corp (Director · Jul 27, 2021 – Jul 28, 2023 · Past); Oncorus Inc (Director · Oct 1, 2020 – Feb 17, 2021 · Past); Acutus Medical Inc. (Director · Aug 5, 2020 – Jan 27, 2025 · Past); Deerfield Healthcare Technology Acquisitions Corp (Director · Jul 16, 2020 – Jul 21, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past); AdaptHealth Corp. (Director · Feb 15, 2018 – Nov 8, 2019 · Past); Alpine Immune Sciences Inc (Director · Sep 12, 2016 – Sep 12, 2016 · Past); AveXis Inc (Director · Sep 3, 2015 – Feb 10, 2016 · Past) | Director · Since at least Jul 28, 2021 |
| Christy Oliger Other companies: Zenas BioPharma, Inc. (Director · Since at least Aug 13, 2026); Bicara Therapeutics Inc. (Director · Since at least Jul 28, 2026); LAVA Therapeutics NV (Director · Since at least Jan 1, 2025); Vera Therapeutics, Inc. (Director · Since at least Jun 7, 2024); Replimune Group, Inc. (Director · Since at least Dec 1, 2021); Karyopharm Therapeutics Inc. (Director · Since at least Aug 28, 2020); RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Sierra Oncology Inc (Director · Jun 2, 2021 – Jul 1, 2022 · Past); Reata Pharmaceuticals Inc (Director · Apr 15, 2021 – Sep 26, 2023 · Past) | Director · Since at least Jun 18, 2025 |
| Sapna Srivastava Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Aura Biosciences, Inc. (Director · Since at least Oct 28, 2021); Tourmaline Bio Inc. (Director · Since at least May 6, 2021); Innoviva, Inc. (Director · Jan 1, 2023 – Jun 17, 2024 · Past); Social Capital Suvretta Holdings Corp II (Director · Jun 29, 2021 – Jun 29, 2021 · Past); Intellia Therapeutics, Inc. (Chief Financial & Stategy Offr · May 5, 2016 – May 5, 2016 · Past); Medavail Holdings Inc (Director · Feb 8, 2013 – Jan 12, 2015 · Past) | Director · Since at least Jul 28, 2021 |
| Andrew A F Hack Other companies: Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); BCLS Acquisition Corp (Chief Financial Officer, Director · Oct 21, 2020 – Oct 26, 2020 · Past); Dynavax Technologies Corporation (Director · Aug 12, 2019 – Aug 8, 2023 · Past); Allena Pharmaceuticals Inc (Director · Jun 8, 2018 – Nov 17, 2020 · Past); Editas Medicine, Inc. (Chief Financial Officer · Feb 2, 2016 – Feb 4, 2019 · Past) | Director · Jul 28, 2021 – Dec 11, 2024 · Past |
| Anna Protopapas Other companies: Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Dicerna Pharmaceuticals Inc (Director · Jan 23, 2019 – Jun 3, 2021 · Past); Bioverativ Inc (Director · Feb 28, 2017 – Mar 8, 2018 · Past); Ariad Pharmaceuticals Inc (Director · Feb 1, 2016 – Feb 16, 2017 · Past) | Director · Since at least Mar 30, 2022 |
| Ron Squarer Other companies: ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Travere Therapeutics, Inc. (Director · Since at least Apr 10, 2017); Deciphera Pharmaceuticals LLC (Director · Dec 4, 2019 – Jun 11, 2024 · Past); Hospira Inc (Chief Commercial Officer · Jan 7, 2009 – Feb 24, 2011 · Past) | Director · Since at least Dec 10, 2025 |
| Cameron Wheeler Other companies: Oncorus Inc (Director · Oct 1, 2020 – Oct 1, 2020 · Past); Q32 Bio Inc. (Director · Mar 27, 2018 – Jun 6, 2019 · Past) | Director · Since at least Jul 28, 2021 |
| Grant Bogle Other companies: Epizyme Inc (President and CEO, Director · Sep 2, 2019 – Aug 12, 2022 · Past); Tesaro Inc (Sr. VP, Chief Commercial Ofc · Jul 13, 2015 – Jan 22, 2019 · Past) | Director · Since at least Dec 5, 2024 |
| Ron Squarer Other companies: ADC Therapeutics SA (Chairman · Since at least Jun 3, 2026); Travere Therapeutics, Inc. (Director · Since at least May 21, 2026) | Director · Since at least Dec 10, 2025 |
| Alexandra Balcom Other companies: Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025) | Chief Financial Officer · Since at least Jul 28, 2021 |
| Dwight Gary Gilliland Other companies: Labcorp Holdings Inc. (Director · Since at least Oct 30, 2017) | Director · Jul 28, 2021 – Jun 12, 2024 · Past |
| Michael L Meyers Other companies: Syndax Pharmaceuticals, Inc. (SVP, Chief Medical Officer · Mar 2, 2016 – Feb 2, 2022 · Past) | Director · Since at least Oct 4, 2022 |
| Benjamin Lane | See Remarks · Since at least Mar 16, 2026 |
| Christopher Durant Turner | Chief Medical Officer · Since at least Jul 28, 2021 |
| Constantin Fest | Investor Relations · Since at least Jun 9, 2026 |
| Darlene Noci | Chief Development Officer · Since at least Jul 28, 2021 |
| Deborah Ann Miller | Chief Legal Officer · Since at least Jul 28, 2021 |
| Emily Conley | Director · Feb 2, 2022 – Aug 23, 2024 · Past |
| Georg Pirmin Meyer | Chief International Officer · Since at least May 27, 2026 |
| Henry E Pelish | Chief Scientific Officer · Since at least Jul 9, 2024 |
| James Richard Porter | President and CEO, Director · Since at least Jul 28, 2021 |
| Joseph Pearlberg | Director · Since at least Jul 28, 2021 |
| Matthew Shair | Director · Since at least Jul 28, 2021 |
| Robert Bowers Jackson | Director · Jul 28, 2021 – Jul 28, 2021 · Past |